These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 1871865)
1. Plasma MHC class I expression in cardiac graft patients: donor-specific soluble antigen in a presensitised graft patient. Zavazava N; Kraatz E; Gassel AM; Müller-Ruchholtz W Transplant Proc; 1991 Aug; 23(4):2258-60. PubMed ID: 1871865 [No Abstract] [Full Text] [Related]
2. Computer-assisted densitometric analysis for quantification of cell surface antigen expression in monkey cardiac allografts: correspondence to histopathologic grade of rejection. Kitamura M; Lackides GA; Billingham ME; Clayberger C; Starnes VA Transplant Proc; 1993 Feb; 25(1 Pt 2):924-7. PubMed ID: 8442269 [No Abstract] [Full Text] [Related]
3. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells. Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544 [No Abstract] [Full Text] [Related]
4. Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected. Jaskłowska-Englisz M; Olszewski WL Transplant Proc; 1994 Dec; 26(6):3463. PubMed ID: 7998224 [No Abstract] [Full Text] [Related]
5. Sequential studies of major histocompatibility complex antigen expression (common class I and class II determinants, DR and DQ) in cardiac biopsies following human cardiac transplantation. Suitters A; Rose M; Khaghani A; Yacoub M Transplant Proc; 1987 Feb; 19(1 Pt 3):2566-7. PubMed ID: 3274565 [No Abstract] [Full Text] [Related]
6. Induction of acute rejection by indirect recognition of donor MHC antigens. Terness P; Dufter C; Otto G; Opelz G Transplant Proc; 1995 Feb; 27(1):457-8. PubMed ID: 7879060 [No Abstract] [Full Text] [Related]
7. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats. Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050 [TBL] [Abstract][Full Text] [Related]
8. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571 [TBL] [Abstract][Full Text] [Related]
9. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694 [TBL] [Abstract][Full Text] [Related]
10. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium. Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729 [TBL] [Abstract][Full Text] [Related]
12. Studies of major histocompatibility complex class I/II expression on sequential human heart biopsy specimens after transplantation. Sell KW; Tadros T; Wang YC; Hertzler G; Knopf WD; Murphy DA; Ahmed-Ansari A J Heart Transplant; 1988; 7(6):407-18. PubMed ID: 2463352 [TBL] [Abstract][Full Text] [Related]
13. Expression of soluble class I molecules in healthy persons and renal graft patients. Zavazava N; Westphal E; Olofsson L; Treumer J; Eckstein V; Müller-Ruchholtz W Transplant Proc; 1990 Aug; 22(4):1876-7. PubMed ID: 2389468 [No Abstract] [Full Text] [Related]
14. Expression of class I and class II major histocompatibility complex (MHC) antigens in rejecting human heart grafts. Ippoliti G; Lazzaro A; Goggi C; Malavasi F; Di Franco L; Martinelli L; Ascari E; Vigano' M Transplant Proc; 1989 Feb; 21(1 Pt 1):445-6. PubMed ID: 2650172 [No Abstract] [Full Text] [Related]
15. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease. Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428 [TBL] [Abstract][Full Text] [Related]
16. Does endotoxin accelerate rejection in a cardiac allograft model? Pirenne J; Médot M; Battafarano R; Benedetti E; Kim S; Dunn DL Transplant Proc; 1996 Oct; 28(5):2463-4. PubMed ID: 8907903 [No Abstract] [Full Text] [Related]
17. Effect of modulation of donor class II antigen expression on the survival of rat cardiac allografts. Barron PT; Tyerman K; McLeish M; Thiru S; Collier SJ Transplant Proc; 1990 Aug; 22(4):1931-2. PubMed ID: 2117818 [No Abstract] [Full Text] [Related]
18. Immunosuppressive effect of soluble class I antigen and its complexes with monoclonal antibody on advanced heart graft rejection in rats. Sumimoto R; Kamada N Transplant Proc; 1991 Feb; 23(1 Pt 1):86-8. PubMed ID: 1990706 [No Abstract] [Full Text] [Related]
19. Sequential analysis of monomorphic and polymorphic major histocompatibility complex antigen expression in human heart allograft biopsy specimens. Steinhoff G; Wonigeit K; Schäfers HJ; Haverich A J Heart Transplant; 1989; 8(5):360-70. PubMed ID: 2552061 [TBL] [Abstract][Full Text] [Related]
20. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant. Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]